Finance

Lists
C1AH34:BVMF
Cardinal Health Inc Brazilian Depositary Receipt
1 192,80 BRL
0,00%
(0,00) 1D
9-окт., 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for C1AH34...
Open
1 188,00 BRL
High
1 192,80 BRL
Low
1 188,00 BRL
Mkt. cap
55,01 млд
Avg. vol.
11,00
Volume
3,00
52-wk high
1 274,52 BRL
52-wk low
901,39 BRL
Shares outstanding
231,56 млн
No. of employees
61 миң
Open
1 188,00 BRL
High
1 192,80 BRL
Low
1 188,00 BRL
Mkt. cap
55,01 млд
Avg. vol.
11,00
Volume
3,00
52-wk high
1 274,52 BRL
52-wk low
901,39 BRL
Shares outstanding
231,56 млн
No. of employees
61 миң
News stories
From web sources and news partners
Profile
Cardinal Health Technologies, LLC doing business as Cardinal Health, is an American multinational health care services company, and the 15th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States. Wikipedia
About Cardinal Health Inc Brazilian Depositary Receipt
CEOJason Hollar
Employees61,3 миң
Founded1971
HeadquartersДублин, Огайо, Америка Кошмо Штаттары
SectorHealth care provider
Last report
2026-ж., 11-авг.
Fiscal period
Q4 2026
2,60 USD / 2,42 USD
+7,41%beat
Revenue / Est. (USD)
63,67 млд / 65,11 млд
-2,20%miss
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
64,01 млд
65,63 млд
60,94 млд
63,67 млд
Cost of goods sold
61,69 млд
63,23 млд
58,44 млд
61,11 млд
Cost of revenue
61,69 млд
63,23 млд
58,44 млд
61,11 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,46 млд
1,50 млд
1,54 млд
1,62 млд
Operating expense
1,55 млд
1,59 млд
1,64 млд
1,71 млд
Total operating expenses
63,24 млд
64,82 млд
60,08 млд
62,82 млд
Operating income
771,00 млн
809,00 млн
861,00 млн
847,00 млн
Other non operating income
10,00 млн
11,00 млн
-16,00 млн
30,00 млн
EBT including unusual items
598,00 млн
630,00 млн
392,00 млн
554,00 млн
EBT excluding unusual items
701,00 млн
732,00 млн
744,00 млн
794,00 млн
Income tax expense
144,00 млн
159,00 млн
12,00 млн
154,00 млн
Effective tax rate
24,08%
25,24%
3,06%
27,80%
Other operating expenses
-
-
-
-
Net income
450,00 млн
467,00 млн
399,00 млн
398,00 млн
Net profit margin
0,70%
0,71%
0,65%
0,62%
Earnings per share
2,55
2,63
3,17
2,60
Interest and investment income
-
-
-
-
Interest expense
-80,00 млн
-88,00 млн
-101,00 млн
-103,00 млн
Net interest expenses
-80,00 млн
-88,00 млн
-101,00 млн
-103,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
1,00 млд
1,04 млд
1,11 млд
1,09 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору